Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa/Entacapone vs Standard Levodopa in Parkinson's Disease
NCT00143026Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, double-blind trial of entacapone in Parkinson's disease (PD) (2 arms), sponsored by Novartis. Primary endpoint: Parkinson's Disease-Questionnaire 8. Started Jul 2005; status: completed.
02
Drugs
entacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00143026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143026.